Latest News & Features
Americas
The US Federal Trade Commission has approved a final order settling charges that pharmaceutical company Hikma’s buyout of Roxane Laboratories and Boehringer Ingelheim Roxane would be anticompetitive. 6 May 2016
Americas
AstraZeneca has completed its acquisition of pharmaceutical company Takeda’s respiratory business. 5 May 2016
Americas
Pharmaceutical company Allergan has received approval from the US Food and Drug Administration to launch a generic version of a cholesterol drug owned by AstraZeneca. 5 May 2016
Americas
CRISPR is only part of the gene editing story, and by studying the patents associated with all of the various methods, a much clearer picture of the entire field can be generated, says Tony Trippe, senior patent analyst for Thomson Reuters. 5 May 2016
Big Pharma
Law firm Cooley has hired Colm Murphy as a partner in the firm’s life sciences patent counselling and prosecution practice in London. 4 May 2016
Asia-Pacific
Australia’s patent system is “poorly targeted” and protection for pharmaceutical inventions is “excessive”, according to a government advisory committee. 4 May 2016
Americas
A judge assessing a patent dispute between Merck and Gilead centring on hepatitis C treatments has allowed Gilead to submit new evidence of jurors allegedly being misled. 3 May 2016
Africa
The Biotechnology Innovation Organization has welcomed the US Trade Representative’s “Special 301 Report”, which it said “aims to advance global IP rights in biotechnology in a number of constructive ways”. 29 April 2016
Africa
Advocate group Médecins Sans Frontières delivered a suitcase full of syringes to the London headquarters of pharmaceutical company GSK in protest at the price of a pneumonia vaccine. 28 April 2016
Africa
Ahead of the English Court of Appeal’s hearing in May in the Warner-Lambert case on second medical use patents, Charlotte Weekes and Tamsin Cornwell of Pinsent Masons examine some of the unanswered questions. 28 April 2016